Financial Data and Key Metrics Changes - For the full year of 2025, the company reported record sales of $1.037 billion, an increase of 8.8% compared to the prior year, marking the first time sales surpassed $1 billion [5] - Record earnings from operations reached $209 million, up 14.4%, and record Adjusted EBITDA was $275 million, an increase of 9.8% from the previous year [5] - Q4 consolidated revenues were $264 million, a 9.8% increase year-over-year, with GAAP earnings from operations of $52 million, up 10.2% [12][13] - Q4 Adjusted EBITDA was $68 million, an increase of 8.1%, with a net income of $39 million, reflecting a 16.8% increase [13][18] Business Segment Data and Key Metrics Changes - The Human Nutrition and Health segment generated sales of $166 million, a 12.7% increase from the prior year, with earnings from operations of $37 million, up 8.9% [19][20] - The Animal Nutrition and Health segment reported sales of $61 million, a 4.9% increase, with earnings from operations of $6 million, up 8.6% [20][21] - The Specialty Products segment delivered sales of $35 million, a 6% increase, with earnings from operations of $11 million, up 5.5% [23] Market Data and Key Metrics Changes - More than half of the sales growth in 2025 came from markets outside the United States, indicating a strong international demand [8] - The dairy market remains healthy, particularly for dairy protein, while the European market for feed-grade choline has shown modest improvement following anti-dumping duties [14][22] Company Strategy and Development Direction - The company continues to invest in strategic growth priorities, including expanding sales and marketing reach both domestically and internationally [8] - Significant investments were made in plant and equipment to support growth, including a new microencapsulation manufacturing facility [10] - The company aims to reduce greenhouse gas emissions and water usage by 25% by 2030, having already surpassed its 2030 goal for emissions reduction [10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate macroeconomic challenges and maintain growth momentum [24] - The company is well-positioned to deliver continued top and bottom-line growth in 2026, supported by strong competitive positions and a differentiated product portfolio [24] Other Important Information - The company repurchased approximately 685,000 shares at an average cost of $158 per share, marking a commitment to returning capital to shareholders [11] - The annual dividend was increased from $0.87 to $0.96 per share, representing a 10% year-over-year increase [11][12] Q&A Session Summary Question: Discussion on the partnership with the New York Jets - Management highlighted the successful partnership, which has helped change the dialogue around the importance of choline for adult health, leading to increased adoption in various products [29][30] Question: Planned sales and promotional activities for 2026 - The company plans to continue its partnerships with the Jets and Bayern Munich, while also increasing social media and digital marketing efforts [45][51] Question: Impact of the Supreme Court decision on tariffs - Management expressed confidence in managing potential disruptions, noting that the theoretical impact of tariffs was manageable and that they have strategies in place to mitigate risks [46][48] Question: Update on international growth and pricing dynamics in Europe - Management confirmed improvements in Europe following the final ruling on anti-dumping duties, with increased volumes and firming prices expected [71][72]

Financial Data and Key Metrics Changes - For the full year of 2025, the company reported record sales of $1.037 billion, an increase of 8.8% compared to the prior year, marking the first time sales surpassed $1 billion [5] - Record earnings from operations reached $209 million, up 14.4%, and record Adjusted EBITDA was $275 million, an increase of 9.8% from the previous year [5] - Fourth quarter consolidated revenues were $264 million, a 9.8% increase year-over-year, with GAAP earnings from operations of $52 million, up 10.2% [12][13] - Quarterly adjusted EBITDA was $68 million, an increase of 8.1%, with consolidated net income at $39 million, up 16.8% [13][18] Business Segment Data and Key Metrics Changes - The human nutrition and health segment generated sales of $166 million, a 12.7% increase from the prior year, with earnings from operations of $37 million, up 8.9% [19][20] - The animal nutrition and health segment reported sales of $61 million, a 4.9% increase, with earnings from operations of $6 million, up 8.6% [20][21] - The specialty products segment delivered sales of $35 million, a 6% increase, with earnings from operations of $11 million, up 5.5% [22][23] Market Data and Key Metrics Changes - More than half of the sales growth in 2025 came from markets outside the United States, indicating a strong international demand [8] - The dairy market remains healthy, particularly for dairy protein, while modest improvements were noted in the European feed-grade choline market following anti-dumping duties [14][21] Company Strategy and Development Direction - The company continues to invest in strategic growth priorities, including expanding sales and marketing reach both domestically and internationally [8][10] - Significant investments were made in plant and equipment to support growth, including a new microencapsulation manufacturing facility in New York State [10][11] - The company is focused on maintaining a strong balance sheet while returning capital to shareholders through share repurchases and dividend increases [11][12] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate macroeconomic challenges and maintain growth momentum [24] - The company anticipates continued top and bottom-line growth in 2026, supported by strong competitive positions and a differentiated product portfolio [24] Other Important Information - The company achieved a net debt reduction to $89 million, with a leverage ratio of 0.3 [19] - The annual dividend was increased from $0.87 to $0.96 per share, marking the 17th consecutive year of double-digit growth [11][12] Q&A Session Summary Question: Discussion on the partnership with the New York Jets - Management highlighted the successful partnership, which has shifted the dialogue around the importance of choline for adult health, leading to increased adoption in various products [30][34] Question: Updates on clinical trials and their potential impact - Management confirmed ongoing clinical trials, with several expected to conclude in 2026, which could lead to new sales opportunities based on positive results [38][39] Question: Planned sales and promotional activities for 2026 - The company plans to enhance marketing efforts through social media and digital marketing, alongside existing partnerships with professional sports teams [49][50] Question: Impact of recent tariff decisions - Management expressed confidence in managing potential disruptions from tariff changes, noting that previous impacts were manageable and the company is well-positioned [46][48] Question: Effective tax rate assumptions - The effective tax rate is expected to be around 23% for modeling purposes, consistent with previous years [52] Question: International growth and pricing dynamics in Europe - Management reported improvements in European markets following recent regulatory changes, with expectations for continued growth in both volume and pricing [70][72][75]

Core Viewpoint - Sanoma Corporation has executed a share buyback, acquiring 15,500 shares at an average price of €9.10, totaling €141,050, in compliance with European regulations [1][2]. Group 1: Share Buyback Details - The share buyback occurred on 20 February 2026, with the highest price per share being €9.13 and the lowest at €9.05 [1]. - Following this transaction, the company holds a total of 894,358 of its own shares [2]. Group 2: Company Overview - Sanoma is a learning and media company operating across Europe, focusing on providing quality educational content and solutions [2][4]. - The company employs nearly 5,000 professionals and reported net sales of approximately €1.3 billion in 2025, with an adjusted operating profit margin of 14.4% [5]. Group 3: Strategic Focus - Sanoma aims for organic growth in K12 education and plans to accelerate this through value-creating mergers and acquisitions [4]. - The company is committed to sustainability, aligning its strategy with the UN Sustainable Development Goals and emphasizing the responsible use of AI [4].

So how do we redefine how India lives, works and dreams. But more important is why do we redefine it. We at Dela we really feel right at the beginning when we start working on a business we work on the purpose because every single entrepreneur every single enterprise in the world needs to do that.If the purpose and the calling is stronger than you need to make money you'll end up delivering impact. In this case our purpose has been simple. How do we add yours to life and life to yours. How do we add years t ...

Wanblad reiterated expectations for completion about 12–18 months from the announcement, putting the estimated closing window between September 2026 and March 2027. He also said a $4.5 billion special dividend is expected to be payable to Anglo American shareholders of record around completion. When asked about U.S. approvals, Wanblad said all required approvals applied for have been received, with only South Korea and China outstanding.Anglo American also described progress toward its proposed merger with ...

Summary of L'Oréal 2026 Conference Call Company Overview - **Company**: L'Oréal (OTCPK:LRLC.F) - **Industry**: Global beauty - **Sales**: EUR 44 billion in 2025 - **Profit**: EUR 6.4 billion - **Units Sold**: 7 billion globally - **Employees**: 95,000 - **Market Cap**: Approximately EUR 200 billion - **Brand Portfolio**: 40 global brands sold in 150 countries [1][3][4] Core Financial Performance - **2025 Performance**: Strong financial results despite geopolitical challenges, with L'Oréal outperforming the beauty market, which grew around 3.5% [4][10] - **Growth Rate**: L'Oréal achieved a global growth rate of +4% in 2025, with notable acceleration in the second half of the year [4][10] - **Divisional Growth**: - Mass market (consumer products): +3.5% - Luxury: Slower growth - Dermatological beauty: Fastest-growing division, accelerated in the second half - Professional products: +7.5% [6][10] Market Dynamics - **Emerging Markets**: Close to +10% growth, with Southeast Asia at +11% and Latin America at +8% [9] - **US Market**: Accelerated growth from +2% in the first half to +4% in the second half [10] - **China Market**: Positive growth returning, with +1% in the first half and +5% in the second half [10] E-commerce and Innovation - **E-commerce Growth**: Represents 30% of sales, up from 5% a decade ago, growing at 13% [12][13] - **Investment in Technology**: Record investment of EUR 1.5 billion in technology, including AI and R&D [17] - **Innovation Rate**: Increased by 150 basis points, with 725 patents filed in 2025, marking a record year for innovation [22][23] Acquisitions and Strategic Moves - **Major Acquisitions**: - Kering Beauty, including high-end brands like Creed and licenses for Bottega Veneta and Balenciaga [24] - Medik8 and Color Wow, enhancing skincare and styling capabilities [24] - Increased stake in Galderma from 10% to 20% [25][26] Sustainability and Ethical Leadership - **Sustainability Recognition**: Received a triple A rating from CDP for the 10th consecutive year, emphasizing L'Oréal's commitment to sustainability [16] Future Outlook - **Market Growth Potential**: Targeting 2 billion consumers over the next decade, with a focus on emerging middle classes and younger demographics [28][29] - **Diversity in Beauty**: Addressing diverse consumer needs, including different hair types and skin tones, to capture new market segments [30] - **Skincare Ambitions**: Plans to enhance skincare offerings, leveraging acquisitions and innovations to meet growing consumer demand [38][39] US Market Insights - **US Subsidiary Performance**: Accounts for 27% of group turnover, with consistent growth and a strong local production footprint [44][45] - **Market Share**: L'Oréal holds a 13% share in the US beauty market, significantly outperforming competitors [50] - **Consumer Segmentation**: Targeting diverse demographics, including Gen Z, millennials, and older consumers, with tailored brand strategies [56][58] Conclusion - L'Oréal is positioned for continued growth through innovation, strategic acquisitions, and a strong focus on e-commerce and sustainability, with a robust outlook for the beauty market in the coming years [41][42]

Financial Data and Key Metrics Changes - In Q4 2025, adjusted net earnings were $83 million, or $0.41 per share, benefiting from strong production and elevated metal prices [22] - Full year 2025 adjusted net earnings were $229 million, or $1.12 per share [22] - Consolidated all-in sustaining costs (AISC) on a byproduct basis in Q4 were $1,646 per ounce, while full year AISC was $1,614 per ounce, outperforming guidance [23][24] - Cash balance at the end of 2025 was $529 million, with total liquidity reaching $929 million [25][26] Business Line Data and Key Metrics Changes - Mount Milligan produced over 44,000 ounces of gold and 13 million pounds of copper in Q4 2025, with full year production of over 147,000 ounces of gold and 50 million pounds of copper [13][14] - Öksüt produced over 26,500 ounces of gold in Q4 2025, with full year production exceeding guidance at over 127,700 ounces [16] - AISC for Mount Milligan in Q4 was $913 per ounce, significantly lower than the previous quarter [15] - AISC for Öksüt in Q4 was $1,748 per ounce, higher due to lower gold ounces sold and increased sustaining CapEx [16][17] Market Data and Key Metrics Changes - Average realized price for gold in Q4 was $3,415 per ounce and for copper was $4.69 per pound [22] - Molybdenum sold in Q4 amounted to 3.6 million pounds at an average price of $23.78 per pound [22] Company Strategy and Development Direction - The company is focused on a self-funded growth strategy, with projects like Mount Milligan, Goldfield, and Kemess being key growth opportunities [5][11] - The Kemess project has a robust economic profile with an after-tax NPV of $1.1 billion and an IRR of 16% [8] - The company aims to maintain a disciplined approach to capital allocation while returning capital to shareholders [30] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in generating strong cash flow in 2026, which will support growth projects and shareholder returns [5][26] - The company is committed to protecting and expanding margins through disciplined cost management [27] - Management highlighted the importance of ongoing exploration and technical work to enhance the growth pipeline [11][28] Other Important Information - The company received all required permits for Mount Milligan operations through 2035, including a 10% increase in plant throughput starting in 2028 [12] - Operations at the Langeloth facility were suspended following an explosion, with repairs expected to cost $5-$10 million [19][20] Q&A Session Summary Question: Langeloth suspension and inventory build - Management indicated that concentrate purchases will continue during the shutdown, leading to an inventory build [32][33] Question: Water management projects at Mount Milligan - Management clarified that water management is an ongoing process, with some capital expenditures being slightly higher than previous years [35][37] Question: Kemess PFS and resource updates - Management stated that the PFS aims to tighten assumptions and advance engineering, with potential for resource expansion through further drilling [41][42] Question: CapEx increase at Thompson Creek - Management explained that the CapEx increase is due to various factors, including inflation and maintenance, and that it is difficult to fix the number precisely [46][48] Question: Cost discipline and performance - Management attributed strong cost performance to site-wide optimization programs and the benefits from byproduct copper prices [50][52] Question: Endako mill value - Management confirmed that the current strategy is to focus on Thompson Creek before considering any actions regarding the Endako mill [58][60]

Financial Data and Key Metrics Changes - In Q4 2025, adjusted net earnings were $83 million, or $0.41 per share, benefiting from strong production and elevated metal prices [21] - Full year 2025 adjusted net earnings were $229 million, or $1.12 per share [21] - Consolidated all-in sustaining costs (AISC) on a byproduct basis for Q4 were $1,646 per ounce, and for the full year, it was $1,614 per ounce, outperforming guidance [22][23] - Cash balance at the end of 2025 was $529 million, with total liquidity at $929 million [25][26] Business Line Data and Key Metrics Changes - Mount Milligan produced over 44,000 ounces of gold and 13 million pounds of copper in Q4 2025, with full year production of over 147,000 ounces of gold and 50 million pounds of copper [13] - Öksüt produced over 26,500 ounces of gold in Q4 2025, with full year production exceeding guidance at over 127,700 ounces [16] - AISC for Mount Milligan in Q4 was $913 per ounce, significantly lower than the previous quarter [14] - AISC for Öksüt in Q4 was $1,748 per ounce, higher due to lower gold ounces sold and increased sustaining CapEx [16][17] Market Data and Key Metrics Changes - Average realized price for gold in Q4 was $3,415 per ounce and for copper was $4.69 per pound [22] - Molybdenum sold in Q4 was approximately 3.6 million pounds at an average price of $23.78 per pound [22] Company Strategy and Development Direction - The company is focused on a self-funded growth strategy, with projects like Mount Milligan, Goldfield, and Kemess being key growth areas [5][6] - The Kemess project has a robust economic profile with an after-tax NPV of $1.1 billion and an IRR of 16% [7] - The company aims to maintain a disciplined approach to capital allocation while returning capital to shareholders [25][29] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in generating strong cash flow in 2026, which will support growth projects and shareholder returns [5][28] - The company is well-positioned for sustainable value delivery in 2026 and beyond, with a stable operating base and clear growth pipeline [29] Other Important Information - The restart of Thompson Creek is progressing, with approximately 27% of infrastructure refurbishment complete [18] - Operations at the Langeloth facility were suspended due to an explosion, with repairs expected to cost $5-$10 million [19][20] Q&A Session Summary Question: Langeloth suspension and inventory build - Management indicated that concentrate purchases will continue during the shutdown, leading to an inventory build [32][33] Question: Water management projects at Mount Milligan - Management clarified that water management is an ongoing process, with some capital expenditures expected to be slightly higher this year [35][36] Question: Capital expenditure increase at Thompson Creek - Management explained that the increase is due to various factors including inflation and maintenance, with no significant changes in physical equipment costs expected [46][48] Question: Cost discipline across the portfolio - Management attributed cost performance to strong operational discipline and the benefits from byproducts, particularly copper [50][51] Question: Update on Endako mill - Management stated that the current strategy is to focus on Thompson Creek before considering any actions regarding Endako [57][58]

Nicolas HIERONIMUS Chief Executive Officer WORLD LEADER IN BEAUTY €44Bn €6.4Bn 2025 SALES 2025 NET PROFIT1 >7Bn >150 UNITS SOLD COUNTRIES 95,000 ~ €200Bn EMPLOYEES MARKET CAPITALIZATION2 1 Net Profit excluding nonrecurring items after non controlling interests. 2 As of 31 May 2026. PERFORMING TRANSFORMING ACCELERATION TO PREPARE FUTURE GROWTH ENGINES 1 2025 like-for-like sales growth, adjusted for the phasing related to the 2024 and 2025 IT transformation. 1 ~ +3.5%1 MARKET 1 L'Oréal beauty market estimates ...

Core Insights - NEXE Innovations Inc. has shipped 315,000 BPI-certified compostable coffee pods year-to-date, indicating strong repeat demand and SKU expansion [1][2] Group 1: Product and Market Expansion - The orders were fulfilled for ecoBeans Coffee and a North American office coffee services distributor, showcasing NEXE's growth in retail and commercial channels [2] - The shipments included 20 SKUs, with 8 being newly introduced products, highlighting product line expansion and deeper customer penetration [2] - NEXE's North American OCS distribution partner is exploring converting additional brands to the NEXE Pod platform, reflecting confidence in the technology as a scalable solution [2][3] Group 2: Revenue and Customer Engagement - NEXE is building a solid base of recurring revenue and engaging with multiple national coffee brands interested in transitioning to compostable coffee pods, indicating a growing interest in environmentally friendly solutions [3] - The company is experiencing an increase in inbound inquiries from potential customers as awareness of the NEXE Pod rises [3] Group 3: Product Features and Certification - The NEXE Pod is fully compostable and compatible with Keurig brewing systems, certified by the Biodegradable Products Institute (BPI) [4] - The pod meets strict North American standards for industrial compostability, including disintegration, biodegradation, and toxin-free composition [4]